Arphra/Issuer/VRTX

VRTX

Vertex Pharmaceuticals Incorporated

HealthcareBiotechnologyUSUSD

$447.54

+0.50%Live · FMPMay 29, 2026

AI Brief

Market cap

$113.59B

52w range

362.50 – 507.92

P / E

—

EPS

—

Volume

1.89M

Revenue · FY

$12.07B

+9.57% YoY

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

$8.21M

10 txns

Net flow

−$8.21M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$425.84

Change

-4.40%

Period high

$499.17

Period low

$366.54

Period start

$445.432025-06-02

Through 2026-05-04

Peers

Price change · trailing returns

Live · FMP

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-0.10%	+2.06%	+5.57%	-9.92%	+5.16%	-1.28%	+0.47%	+38.29%	+113.45%	+376.61%	+9845.33%

Aftermarket

Live · FMP

Jun 01, 08:41 AM

Last trade

$446.70

1 sh

Bid

$444.00

1 sh

Ask

$449.67

24 sh

Spread

$5.670

Sector & industry today

Live · FMP

Sectors

Technology
+0.21%
Basic Materials
+0.15%
Financial Services
-0.43%
Industrials
-0.48%
Energy
-0.58%
Consumer Defensive
-0.79%
Consumer Cyclical
-0.85%
Real Estate
-0.98%
Healthcare
-1.37%
Communication Services
-1.47%
Utilities
-2.07%

Top industries (issuer's industry highlighted)

Biotechnology
+0.06%
Software - Infrastructure
+6.80%
Coal
-6.27%
Information Technology Services
+6.00%
Medical - Healthcare Information Services
+5.23%
Other Precious Metals
+3.84%
Broadcasting
-3.48%
Silver
+2.89%
Renewable Utilities
-2.75%
Software - Application
+2.71%
Travel Lodging
-2.70%
Internet Content & Information
-2.61%

Fair value

Football field →

Weighted blend

$2,211.96

+394.25% vs spot

Recommendation

Strong Buy

15 of 16 methods

Method spread

4bull11bear

±5% threshold

Analyst PT consensus: $552.27 (+23.40%)

Total assets

$26.14B

Total debt

$3.88B

Cash & equiv

$5.09B

Operating CF

$3.63B

Free cash flow

$3.19B

Buybacks

-$2.02B

Analyst view

DB · price_targets + analyst_grades

Consensus target

$552.27

+23.40% upside

Low

$437.00

Median

$558.00

High

$612.00

Recent actions

0 ↑0 ↓8 hold

Apr 01, 2026
Mar 01, 2026
Feb 01, 2026
Jan 01, 2026
Dec 01, 2025

News

DB · news_items

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q4 Dec 2025	$3.23B	$1.19B	$4.65
Q3 Sep 2025	$3.08B	$1.08B	$4.20
Q2 Jun 2025	$2.96B	$1.03B	$3.99
Q1 Mar 2025	$2.77B	$646.3M	$2.49
Q4 Dec 2024	$2.91B	$913M	$3.50
Q3 Sep 2024	$2.77B	$1.05B	$4.01

Recent insiders

All →

Insider	Action	Shares	Value	Date
Bhatia Sangeeta N. director	Sell	318	$134.75K	May 04, 2026
Liu Joy officer: EVP and Chief Legal Officer	Sell	1,104	$469.22K	May 01, 2026
Liu Joy officer: EVP and Chief Legal Officer	Sell	978	$439.29K	Apr 01, 2026
Bozic Carmen officer: EVP and CMO	Sell	2,329	$1.05M	Mar 27, 2026
Bozic Carmen officer: EVP and CMO	Sell	2,329	$1.12M	Mar 13, 2026
McKechnie Duncan officer: EVP, Chief Commercial Officer	Sell	2,633	$1.31M	Mar 11, 2026

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$12.07B	$4.76B	$3.95B	$15.32	+32.74%
FY 2024	$11.02B	-$232.9M	-$535.6M	$-2.08	-4.86%
FY 2023	$9.87B	$3.83B	$3.62B	$13.89	+36.68%
FY 2022	$8.93B	$4.31B	$3.32B	$12.82	+37.20%
FY 2021	$7.57B	$2.78B	$2.34B	$9.01	+30.92%